Skip to main content
C

Celestra Inc. — Investor Relations & Filings

Ticker · 352770 ISIN · KR7352770002 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 378 across all filing types
Latest filing 2024-05-16 Major Shareholding Noti…
Country KR South Korea
Listing KO 352770

About Celestra Inc.

https://celestrahealth.com/

Celestra Inc. develops and commercializes digital biomarkers for monitoring neurological conditions. The company's core product is the Celestra Health platform, an FDA-designated Class II medical device that provides quantitative gait analysis for patients in their natural environment. The platform utilizes wearable smart insoles equipped with gyroscopes, accelerometers, and pressure sensors to collect movement data. This data is processed by a cloud-based system using advanced machine learning algorithms to measure over 200 aspects of a patient's gait. The system is designed to detect subtle changes in disease progression for conditions such as Multiple Sclerosis and Parkinson’s Disease earlier than traditional clinical assessments. It offers laboratory-grade accuracy, providing clinicians with actionable insights through a proprietary composite index and enabling pharmaceutical firms to assess drug therapy effectiveness more efficiently.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 1% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Supervisory Service in South Korea. This type of filing is required when an entity acquires a significant stake (typically 5% or more) in a publicly traded company. In the provided taxonomy, this corresponds to a 'Major Shareholding Notification'.
2024-05-16 Korean
분기보고서 (2024.03)
Interim / Quarterly Report Classification · 1% confidence The document is a '분기보고서' (Quarterly Report) for Clinomics Inc., covering the period from January 1, 2024, to March 31, 2024. It contains detailed corporate information, capital structure, shareholding changes, and management details, which are characteristic of a formal interim financial report. It is not an announcement of a report (RPA) or a simple certification, as it contains substantive financial and operational data. Q1 2024
2024-05-16 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 1% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details a change in shareholding (specifically the acquisition of convertible bonds) by an individual, Song Ki-dong, in the company Clinomics. This type of filing is used to notify the market of significant ownership changes and falls under the category of Major Shareholding Notification.
2024-05-16 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 1% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the acquisition of convertible bonds by Baro Saving Bank and its affiliate, resulting in a change in their shareholding position in Clinomics. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) as it tracks significant ownership thresholds.
2024-05-14 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 1% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Korea Exchange (KRX) regarding the issuance of convertible bonds (전환사채권 발행결정). This type of filing is a standard regulatory disclosure for capital structure changes and financing activities in the Korean market. It details the terms of the bond, conversion rights, and the use of proceeds. Since it pertains to the issuance of new securities (convertible bonds) and capital changes, it falls under the 'Capital/Financing Update' category.
2024-05-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the acquisition of shares by '제노투자조합1호' in '클리노믹스', resulting in a significant ownership stake (12.84%). This type of filing is specifically categorized as a Major Shareholding Notification (MRQ) in the provided schema.
2024-05-13 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.